Predictions instead of panics: the framework and utility of systematic forecasting of novel psychoactive drug trends

References

• Wiley JL, Marusich JA, Huffman JW, Balster RL, Thomas BF. Hijacking of basic research: the case of synthetic cannabinoids. Methods Rep RTI Press; 2011
   Google Scholar
• Evren C, Bozkurt M, Yavuz KF, Yavuz N, Ulusoy S, Alnak I, et al. Synthetic cannabinoids: crisis of the decade. J Psychiatry Neurological Sci 2013;26:1–11
   Google Scholar
• Gussow L. Special report: coming soon to an ED near you: Bromo-Dragonfly (not an insect), K2 (not a mountain), and Venus (not the planet). Emerg Med News 2010;32:20–21
   Google Scholar
• Roff AN. Bath salts: a ‘scary’ and growing epidemic. Utica Observer Dispatch; 17 July 2012
   Google Scholar
• Cross J. Despite ban, Arizona use of bath salts runs rampant. KTAR, The Voice of Arizona; 30 May 2012
   Google Scholar
• Haig SD, Kelly C, Morden C. A report of an outbreak of toxicity from a novel drug of abuse: ERIC-3. Emerg Med J 2013;30:543–545
   PubMed Web of Science ®Google Scholar
• Lajoie TM, Rich A. “Bath salts”: A new drug epidemic – a case report. Am J Addict 2012;21:572–573
   PubMed Web of Science ®Google Scholar
• Lank PM, Pines E, Mycyk MB. Emergency physicians’ knowledge of cannabinoid designer drugs. West J Emerg Med 2013;14:467
   PubMedGoogle Scholar
• Stogner J, Miller BL. Investigating the ‘bath salt’ panic: the rarity of synthetic cathinone use among students. Drug Alcohol Rev 2013;32:545–549
   PubMed Web of Science ®Google Scholar
• Stogner J, Miller BL. A spicy kind of high: a profile of synthetic cannabinoid users. J Subst Use 2014;19:199–205
   Web of Science ®Google Scholar
• Lange JE, Reed MB, Croff JMK, Clapp JD. College student use of Salvia divinorum. Drug Alcohol Depend 2008;94:263–266
   PubMed Web of Science ®Google Scholar
• Ford JA, Watkins WC, Blumenstein L. Correlates of Salvia divinorum use in a national sample: findings from the 2009 National Survey on Drug Use and Health. Addict Behav 2011;36:1032–1037
   PubMed Web of Science ®Google Scholar
• Johnston LD, O’Malley PM, Bachman JG, Schulenberg J. Monitoring the Future national results on adolescent drug use: overview of key findings, 2012. Ann Arbor, MI: Institute for Social Research, The University of Michigan, 83 pp; 2013
   Google Scholar
• Bronstein AC, Spyker DA, Cantilena LR, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol 2011;49:910–941
   PubMed Web of Science ®Google Scholar
• American Association of Poison Control Centers. AAPCC Issues Statement on the Synthetic Drug Abuse Prevention Act. Released July 11, 2012. Available at: http://www.aapcc.org/alerts/bath-salts/ [accessed May 22 2014]
   Google Scholar
• Dargan P, Wood D. Novel psychoactive substances: classification, Pharmacology and toxicology. London: Academic Press; 2013
   Google Scholar
• Wohlfarth A, Weinmann W. Bioanalysis of new designer drugs. Bioanalysis 2010;2:965–979
   PubMed Web of Science ®Google Scholar
• Erickson T. “Bath salt” abuse hits epidemic proportions. Emerg Physicians Monthly, 13 April 2011. Available at: http://www.epmonthly.com/. [accessed 27 Nov 2013]
   Google Scholar
• Chitwood DD, Murphy S, Rosenbaum M. Reflections on the meaning of drug epidemics. J Drug Issues 2009;39:29–39
   Web of Science ®Google Scholar
• Tolman AW. Crackhead carriers: outbreak narratives and expansion of state power. Avant; 2014. Available at: http://vvvnt.com/media/crack-crisis
   Google Scholar
• Goode E. Ben-Yehuda N. Moral panics: The social construction of deviance. Chichester, UK: John Wiley & Sons; 2010
   Google Scholar
• Reinarman C. The social construction of drug scares. Constructions of deviance: social power, context, and interaction. 1994:92–105
   Google Scholar
• Akers RL. Drugs, alcohol, and society: social structure, process, and policy. Belmont, CA: Wadsworth Publishing Company; 1992
   Google Scholar
• Olives TD, Orozco BS, Stellpflug SJ. Bath salts: the ivory wave of trouble. West J Emerg Med 2012;13:58
   PubMedGoogle Scholar
• Singman-Kaine CE. Emerging drugs: building awareness. Prof Bull Military Police Corps 2011; Fall:18–19
   Google Scholar
• Enos G. Federal officials concerned about ‘bath salts’ and related designer drugs. Alcoholism Drug Abuse Weekly 2011;2
   Google Scholar
• Slomski A. A trip on “bath salts” is cheaper than meth or cocaine but much more dangerous. JAMA 2012;308:2445–2447
   PubMed Web of Science ®Google Scholar
• Hu X, Primack BA, Barnett TE, Cook RL. College students and use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy 2011;6:16
   PubMed Web of Science ®Google Scholar
• Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F. Mephedrone, new kid for the chop?. Addiction. 2011;106:154–161
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of OxyContin® and other opioid analgesics in the United States: 2002–2004. J Pain. 2005;6:662–672
   PubMed Web of Science ®Google Scholar
• Khey DN, Miller BL, Griffin OH. Salvia divinorum use among a college student sample. J Drug Educ 2008;38:297–306
   PubMed Web of Science ®Google Scholar
• Stogner J, Khey DN, Griffin OH, Miller BL, Boman JH. Regulating a novel drug: an evaluation of changes in use of Salvia divinorum in the first year of Florida’s ban. Int J Drug Policy 2012;23:512–521
   PubMed Web of Science ®Google Scholar
• Eisner B. Ecstasy: the MDMA story. Berkeley, CA: Ronin Publishing; 1994
   Google Scholar
• Khey DN, Stogner J, Miller BL. Emerging trends in drug use and distribution. New York: Springer International Publishing; 2014
   Google Scholar
• Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE, Miech RA. Monitoring the Future national survey results on drug use, 1975–2013: Vol. I, Secondary school students. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2014. 630 p
   Google Scholar
• Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend 2012;120:238–241
   PubMed Web of Science ®Google Scholar
• Werse B, Morgenstern C. How to handle legal highs? Findings from a German online survey and considerations on drug policy issues. Drugs Alcohol Today 2012;12:222–231
   Google Scholar
• Ayres TC, Bond JW. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill) health. Legal highs or illegal highs? BMJ Open 2012;2: pii: e000977
   Web of Science ®Google Scholar
• Singleton M, Stogner JM, Miller BL. Awareness of novel drug legality in a young adult population. Am J Crim Justice 2014;39:425--435
   Google Scholar
• Chemerinsky E, Forman J, Hopper A, Kamin S. Cooperative federalism and marijuana regulation. UCLA Law Rev 2014;62:74
   Web of Science ®Google Scholar
• Perrone D, Helgesen RD, Fischer RG. United States drug prohibition and legal highs: how drug testing may lead cannabis users to Spice. Drugs Educ Prev Policy 2012;20:216–224
   Web of Science ®Google Scholar
• Pratt TC, Cullen FT, Blevins KR, Daigle LE, Madensen TD. The empirical status of deterrence theory: a meta-analysis. In: Cullen FT, Wright JP, Blevins KR, eds. Taking stock: the status of criminological theory. New Brunswick, NJ: Transaction Publishers; 2006
   Google Scholar
• Hanson G, Venturelli P, Fleckenstein A. Drugs and society. Boston, MA: Jones & Bartlett Publishers; 2011
   Google Scholar
• Norman J, Grace S, Lloyd C. Legal high groups on the internet – the creation of new organized deviant groups? Drugs Educ Prev Policy 2014;21:14–23
   Web of Science ®Google Scholar
• Miller BL, Boman JH, Stogner JM. Measuring novel drug perceptions: Salvia divinorum, gender, and peer delinquency. Subst Use Misuse 2013;48:65–72
   PubMed Web of Science ®Google Scholar
• Sanders A, Stogner JM, Miller BL. Perception vs. reality: an investigation of the misperceptions concerning the extent of peer novel drug use. J Drug Educ 2013;43:97–120
   PubMed Web of Science ®Google Scholar
• Schmidt MM, Sharma A, Schifano F, Feinmann C. “Legal highs” on the net – evaluation of UK-based websites, products and product information. Forensic Sci Int 2011;206:92–97
   PubMed Web of Science ®Google Scholar
• Winstock A, Mitcheson L, Marsden J. Mephedrone: still available and twice the price. Lancet 2010;376:1537
   PubMed Web of Science ®Google Scholar
• Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 2012;39:234–243
   PubMed Web of Science ®Google Scholar
• Pierre JM. Cannabis, synthetic cannabinoids, and psychosis risk: what the evidence says. Curr Psychiatr 2011;10:49–57
   Google Scholar
• Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K, et al. Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Dtsch Arztebl Int 2009;106:464–467
   PubMed Web of Science ®Google Scholar
• Griffiths P, Sedefov R, Gallegos ANA, Lopez D. How globalization and market innovation challenge how we think about and respond to drug use: ‘Spice’, a case study. Addiction 2010;105:951–953
   PubMed Web of Science ®Google Scholar
• Derlet RW Heischober B. Methamphetamine. Stimulant of the 1990s? Western J Med 1990;153:625
   PubMedGoogle Scholar
• Jenkins P. “The ice age” the social construction of a drug panic. Justice Quart 1994;11:7–31
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: SAMHSA; 2014
   Google Scholar
• Beebe DK, Walley E. Smokable methamphetamine (‘Ice’): an old dog in a different form. Am Fam Physician 1995;51:449–454
   PubMed Web of Science ®Google Scholar
• Linnemann T, Wall T. This is your face on meth: the punitive spectacle of ‘white trash’ in the rural war on drugs. Theoret Criminol 2013;17:315–334
   Web of Science ®Google Scholar
• Coppola M, Mondola R. Bromo-DragonFly: chemistry, pharmacology and toxicology of a benzodifuran derivative producing LSD-like effects. J Addict Res Ther 2012;3:2
   Google Scholar
• Andreasen MA, Telving R, Birkler RI, Schumacher B, Johannsen M. A fatal poisoning involving Bromo-Dragonfly. Forensic Sci Int 2009;183:91–96
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Abuse (EMCDDA). Statistical bulletin 2012. Other substances seized, 2004–2010. Available at: http://www.emcdda.europa.eu/stats12/szrtab21a [accessed 27 May 2014]
   Google Scholar
• Nielsen VT, Høgberg LC, Behrens JK. Bromo-Dragonfly poisoning of 18-year-old male. Ugeskrift for laeger 2010;172:1461
   PubMedGoogle Scholar
• Corazza O, Schifano F, Farre M, Deluca P, Davey Z, Drummond C, et al. Designer drugs on the Internet: a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly. Curr Clin Pharmacol 2011;6:125–129
   PubMedGoogle Scholar
• Higashikawa Y, Suzuki S. Studies on 1-(2-phenethyl)-4-(N-propionylanilino) piperidine (fentanyl) and its related compounds: structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol 2008;26:1–5
   Web of Science ®Google Scholar
• Drug Enforcement Administration. Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), December 2013. Available at: http://www.deadiversion.usdoj.gov/drug_chem_info/acetyl fentanyl.pdf [accessed 30 April 2014]
   Google Scholar
• Ogilvie L, Stanley C, Lewis L, Boyd M, Lozier M. Notes from the field: acetyl fentanyl overdose fatalities-Rhode Island, March–May 2013. MMWR Morb Mortal Wkly Rep 2013;62:703
   PubMed Web of Science ®Google Scholar
• North Carolina Department of Health and Human Services. DHHS issues health advisory for deadly new synthetic drug: acetyl fentanyl detected in specimens associated with three N.C. deaths this year. Available at: http://www.ncdhhs.gov/pressrel/2014/2014-02-19_health_advisory.htm. [accessed 22 May 2014]
   Google Scholar
• Roberts JR. InFocus: Acetyl fentanyl: new drug of abuse more common than assumed. Emerg Med News 2013;35:1–28
   Google Scholar
• Centers for Disease Control and Prevention. Current cigarette smoking among adults – United States, 2005–2012. MMWR Morb Mortal Wkly Rep 2014;63:29–34
   PubMed Web of Science ®Google Scholar
• Schripp T, Markewitz D, Uhde E, Salthammer T. Does e-cigarette consumption cause passive vaping? Indoor Air. 2013;23:25–31
   PubMed Web of Science ®Google Scholar
• Dawkins L, Turner J, Hasna S, Soar K. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addict Behav 2012;37:970–973
   PubMed Web of Science ®Google Scholar
• Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Acute pulmonary effects of sidestream secondhand smoke at simulated car concentrations. Xenobiotica 2013;43:509–513
   PubMed Web of Science ®Google Scholar
• Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an Internet survey. Drug Alcohol Rev 2013;32:133–140
   PubMed Web of Science ®Google Scholar
• Bell K, Salmon A, Bowers M, Bell J, McCullough L. Smoking, stigma and tobacco ‘denormalization’: further reflections on the use of stigma as a public health tool. A commentary on Social Science & Medicine’s Stigma, Prejudice, Discrimination and Health Special Issue (67:3). Soc Sci Med 2010;70:795–799
   PubMed Web of Science ®Google Scholar
• Center for Behavioral Health Statistics and Quality. The DAWN report: bath salts were involved in over 20,000 drug-related emergency department visits in 2011. Center for Rockville, MD; 2013
   Google Scholar
• Center for Behavioral Health Statistics and Quality. The DAWN Report: Drug-related emergency department visits involving synthetic cannabinoids. Rockville, MD. 2012
   Google Scholar
• Archer JRH, Dargan PI, Lee H, Hudson S, Wood DM. Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances. Clin Toxicol 2014;52:160–165
   PubMed Web of Science ®Google Scholar